Page 5 - இந்தியன் காப்புரிமைகள் நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Should India Grant Compulsory Licences to Increase the Supply of Vaccines? While there currently isn t a shortage of vaccines, compulsory licencing can be a powerful public health tool to work around concerns over insufficient supply of important pharmaceutical products. A medic show a vial containing doses of Covishield vaccine during a countrywide inoculation drive against the coronavirus, at BSF Hospital in Jammu, Monday, Jan. 25, 2021. Photo: PTI Trade28/Jan/2021 India’s drug regulator, the Central Drug Standards Control Organisation, approved two coronavirus vaccine candidates – Covishield and Covaxin – for “restricted use” in “emergency” situations. Covaxin is an indigenous vaccine candidate, developed by Bharat Biotech (Hyderabad), the Indian Council of Medical Research (Delhi) and the National Institute of Virology (Pune).

United kingdomDominican republicEl salvadorEuan rochaNatco pharmaBayer corpIndian council of medical research delhiUniversity of oxfordCentral drug standards control organisationIndia serum instituteSupreme courtSerum instituteWhile serum instituteSerum institute of indiaWorld trade organisationNational institute of virology pune